Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Enlighta Inc. (V:NLTA)

Business Focus: Biotechnology & Medical Research (NEC)

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEDI filings for NLTA within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Sep 26, 2024 13:00 ET
Enlighta Inc. Announces Resignation of Director and President
RICHMOND, BC / ACCESSWIRE / September 26, 2024 / Enlighta Inc. (NEX:NLTA.H) announces today that Norman Tsui, a founder and President and long-time director of the company, has resigned from his position effective immediately. Norman has been with Enlighta since its inception in 2010 and played a pivotal role in the company's initial foundations, including the financing, development of its early technology, and the successful public listing on the TSX Venture Exchange.
Read full article
Nov 06, 2023 07:01 ET
Canadian Investment Regulatory Organization Trading Halt - NLTA.H
VANCOUVER, BC, Nov. 6, 2023 /CNW/ - The following issues have been halted by CIRO
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
N/A
--
--
Price to Sales - TTM
--
3.95
3.37
Price to Book - most recent quarter
--
3.48
2.36
Price to Cash Flow per share - TTM
--
5.94
12.55
Price to Free Cash Flow per share - TTM
--
20.06
16.47
See all valuations

Short Report

Date Number of Shares Shorted Net Change
Dec 31, 1969 0 0
Dec 31, 1969 0 0
Dec 31, 1969 0 0
See Short Report

Business Summary

Sector:  Healthcare Industry:  Biotechnology & Medical Research

Enlighta Inc. is engaged in providing software solutions. The Company's software solutions enable enterprises data-driven insights into demand, performance, contract compliance and spend, as well as process automation for demand, selection, invoice validation, vendor governance, and third-party risk monitoring. Its solutions include Enlighta Govern, Enlighta TPRM, Enlighta Assess, and Enlighta DevSmart. The Enlighta Govern offers auditable compliance with regulations, policies, and contracts by third parties and suppliers. The Enlighta TPRM provides automated and auditable third-party risk and compliance monitoring. The Enlighta Assess provides out-of-the-box assessments that can be quickly tailored for client-specific needs. Enlighta DevSmart is involved in the sourcing of proposals and candidates from suppliers for managed services and staffing engagements. It serves industries, such as financial services and insurance, manufacturing, retail, transportation, government, and others.

See business summary

 

Twitter

Search (past week) for $NLTA.CA NLTA.V

  • No tweets found